biote Corp. (BTMD) income statement
BTMDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3066% below fair value
$0.81−0.03 (-3.56%)
Close on Nov 20, 2026Market cap $29.27MP/E 8.1Yield –
biote Corp. financial ratios
See a number that looks wrong?